2023
Ketamine versus ECT for Nonpsychotic Treatment-Resistant Major Depression
Anand A, Mathew S, Sanacora G, Murrough J, Goes F, Altinay M, Aloysi A, Asghar-Ali A, Barnett B, Chang L, Collins K, Costi S, Iqbal S, Jha M, Krishnan K, Malone D, Nikayin S, Nissen S, Ostroff R, Reti I, Wilkinson S, Wolski K, Hu B. Ketamine versus ECT for Nonpsychotic Treatment-Resistant Major Depression. New England Journal Of Medicine 2023, 388: 2315-2325. PMID: 37224232, DOI: 10.1056/nejmoa2302399.Peer-Reviewed Original ResearchConceptsTreatment-resistant major depressionPatient-reported qualityElectroconvulsive therapyMajor depressionECT groupKetamine groupTreatment phaseMusculoskeletal adverse effectsSubanesthetic intravenous ketamineWeeks of treatmentInitial treatment phaseIntravenous ketamineSecondary outcomesPrimary outcomeNoninferiority marginTrial groupECT clinicsNoninferiority trialPatientsComparative effectivenessKetamineClinical sitesAdverse effectsDepressionThree times
2005
Chronic Renal Failure, Hemodialysis, and Electroconvulsive Therapy
Williams S, Ostroff R. Chronic Renal Failure, Hemodialysis, and Electroconvulsive Therapy. Journal Of Ect 2005, 21: 41-42. PMID: 15791177, DOI: 10.1097/01.yct.0000156404.61098.5b.Peer-Reviewed Case Reports and Technical NotesConceptsChronic renal failureElectroconvulsive therapyRenal failureHamilton Depression Rating Scale scoresDepression Rating Scale scoresBilateral electroconvulsive therapyBipolar I depressionRating Scale scoresOral intakeAntidepressant regimensPsychotic depressionPatient populationSevere hypokinesiaScale scoreTherapyHemodialysisRobust responseDepressionRegimensHypokinesiaPatientsFailureIntake